Mirae Asset Global Investments
PCVX icon

Mirae Asset Global Investments’s Vaxcyte PCVX Stock Holding History

Mirae Asset Global Investments’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Sell
24,214
-1,049
-4% -$57K ﹤0.01% 840
2026
Q1 		$1.47M Buy
25,263
+684
+3% +$37.1K ﹤0.01% 793
2025
Q4 		$1.13M Buy
24,579
+1,395
+6% +$62.4K ﹤0.01% 880
2025
Q3 		$835K Buy
23,184
+9,074
+64% +$301K ﹤0.01% 908
2025
Q2 		$459K Buy
14,110
+772
+6% +$25.3K ﹤0.01% 957
2025
Q1 		$926K Buy
13,338
+74
+0.6% +$5.92K ﹤0.01% 828
2024
Q4 		$1.08M Sell
13,264
-1,747
-12% -$173K ﹤0.01% 800
2024
Q3 		$1.7M Buy
15,011
+3,349
+29% +$302K 0.01% 682
2024
Q2 		$919K Sell
11,662
-26,711
-70% -$1.82M ﹤0.01% 786
2024
Q1 		$1.63M Sell
38,373
-12,763
-25% -$884K ﹤0.01% 1301
2023
Q4 		$3.21M Buy
51,136
+296
+0.6% +$15.4K 0.01% 1057
2023
Q3 		$2.59M Buy
50,840
+2,217
+5% +$109K 0.01% 1079
2023
Q2 		$2.42M Buy
48,623
+6,911
+17% +$328K 0.01% 1122
2023
Q1 		$1.56M Buy
41,712
+7,217
+21% +$306K ﹤0.01% 1330
2022
Q4 		$1.65M Buy
34,495
+7,343
+27% +$288K ﹤0.01% 1246
2022
Q3 		$652K Buy
27,152
+9,526
+54% +$241K ﹤0.01% 1722
2022
Q2 		$383K Buy
+17,626
New +$408K ﹤0.01% 1875

Other funds holding PCVX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global Investments's PCVX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Vaxcyte (PCVX) stake by 4.2% in Q2 2026, selling an estimated $57K and leaving 24,214 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Mirae Asset Global Investments first reported a position in PCVX in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.21M in Q4 2023. 127 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Mirae Asset Global Investments held 24,214 shares of Vaxcyte worth $1.41M as of Q2 2026.
  • Mirae Asset Global Investments sold 1,049 Vaxcyte shares in Q2 2026, an estimated $57K.
  • Vaxcyte made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #840 holding.
  • Mirae Asset Global Investments first reported a position in Vaxcyte in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Vaxcyte position peaked at $3.21M in Q4 2023.
  • 127 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.